Valeritas (NASDAQ:VLRX) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Friday.

Valeritas (NASDAQ VLRX) traded up $0.35 during trading on Friday, hitting $4.64. The stock had a trading volume of 29,746 shares, compared to its average volume of 30,941. Valeritas has a twelve month low of $2.00 and a twelve month high of $40.96. The company has a debt-to-equity ratio of 3.54, a current ratio of 3.88 and a quick ratio of 3.20.

A hedge fund recently bought a new stake in Valeritas stock. C WorldWide Group Holding A S purchased a new position in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned about 3.42% of Valeritas at the end of the most recent reporting period. Hedge funds and other institutional investors own 5.74% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally published by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was copied illegally and republished in violation of international trademark & copyright legislation. The original version of this article can be accessed at https://www.dailypolitical.com/2017/12/01/valeritas-vlrx-upgraded-at-valuengine.html.

About Valeritas

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.